Selected research
Market Analysis & Forecast
Global Eszopiclone Market Analysis and Forecast 2026-2032
Market perspective
The global Eszopiclone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Eszopiclone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Eszopiclone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Eszopiclone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Eszopiclone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Eszopiclone include Tasly Pharmaceutical, Sun Pharmaceutical, Kanghong Pharmaceutical, Wockhardt, Tapi Teva, Shanghai Pharmaceuticals Holding, Kanghong Pharmaceutical, Glenmark Life Sciences and Dr. Reddy’s Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Eszopiclone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Eszopiclone, also provides the sales of main regions and countries. Of the upcoming market potential for Eszopiclone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Eszopiclone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Eszopiclone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Eszopiclone sales, projected growth trends, production technology, application and end-user industry.
Eszopiclone Segment by Company
Tasly Pharmaceutical
Sun Pharmaceutical
Kanghong Pharmaceutical
Wockhardt
Tapi Teva
Shanghai Pharmaceuticals Holding
Kanghong Pharmaceutical
Glenmark Life Sciences
Dr. Reddy’s Laboratories
Centaur Pharmaceuticals
Admiron Life
Eszopiclone Segment by Type
Purity Above 98%
Purity Below 98%
Eszopiclone Segment by Application
Tablet
Capsule
Other
Eszopiclone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Eszopiclone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Eszopiclone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eszopiclone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Tasly Pharmaceutical
- Sun Pharmaceutical
- Kanghong Pharmaceutical
- Wockhardt
- Tapi Teva
- Shanghai Pharmaceuticals Holding
- Kanghong Pharmaceutical
- Glenmark Life Sciences
- Dr. Reddy’s Laboratories
- Centaur Pharmaceuticals
- Admiron Life
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Eszopiclone Market by Type
- 1.2.1 Global Eszopiclone Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Purity Above 98%
- 1.2.3 Purity Below 98%
- 1.3 Eszopiclone Market by Application
- 1.3.1 Global Eszopiclone Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Tablet
- 1.3.3 Capsule
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Eszopiclone Market Dynamics
- 2.1 Eszopiclone Industry Trends
- 2.2 Eszopiclone Industry Drivers
- 2.3 Eszopiclone Industry Opportunities and Challenges
- 2.4 Eszopiclone Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Eszopiclone Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Eszopiclone Revenue by Region
- 3.2.1 Global Eszopiclone Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Eszopiclone Revenue by Region (2021-2026)
- 3.2.3 Global Eszopiclone Revenue by Region (2027-2032)
- 3.2.4 Global Eszopiclone Revenue Market Share by Region (2021-2032)
- 3.3 Global Eszopiclone Sales Estimates and Forecasts 2021-2032
- 3.4 Global Eszopiclone Sales by Region
- 3.4.1 Global Eszopiclone Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Eszopiclone Sales by Region (2021-2026)
- 3.4.3 Global Eszopiclone Sales by Region (2027-2032)
- 3.4.4 Global Eszopiclone Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Eszopiclone Revenue by Manufacturers
- 4.1.1 Global Eszopiclone Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Eszopiclone Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Eszopiclone Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Eszopiclone Sales by Manufacturers
- 4.2.1 Global Eszopiclone Sales by Manufacturers (2021-2026)
- 4.2.2 Global Eszopiclone Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Eszopiclone Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Eszopiclone Sales Price by Manufacturers (2021-2026)
- 4.4 Global Eszopiclone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Eszopiclone Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Eszopiclone Manufacturers, Product Type & Application
- 4.7 Global Eszopiclone Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Eszopiclone Market CR5 and HHI
- 4.8.2 2025 Eszopiclone Tier 1, Tier 2, and Tier 3
5 Eszopiclone Market by Type
- 5.1 Global Eszopiclone Revenue by Type
- 5.1.1 Global Eszopiclone Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Eszopiclone Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Eszopiclone Revenue Market Share by Type (2021-2032)
- 5.2 Global Eszopiclone Sales by Type
- 5.2.1 Global Eszopiclone Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Eszopiclone Sales by Type (2021-2032) & (tons)
- 5.2.3 Global Eszopiclone Sales Market Share by Type (2021-2032)
- 5.3 Global Eszopiclone Price by Type
6 Eszopiclone Market by Application
- 6.1 Global Eszopiclone Revenue by Application
- 6.1.1 Global Eszopiclone Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Eszopiclone Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Eszopiclone Revenue Market Share by Application (2021-2032)
- 6.2 Global Eszopiclone Sales by Application
- 6.2.1 Global Eszopiclone Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Eszopiclone Sales by Application (2021-2032) & (tons)
- 6.2.3 Global Eszopiclone Sales Market Share by Application (2021-2032)
- 6.3 Global Eszopiclone Price by Application
7 Company Profiles
- 7.1 Tasly Pharmaceutical
- 7.1.1 Tasly Pharmaceutical Company Information
- 7.1.2 Tasly Pharmaceutical Business Overview
- 7.1.3 Tasly Pharmaceutical Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Tasly Pharmaceutical Eszopiclone Product Portfolio
- 7.1.5 Tasly Pharmaceutical Recent Developments
- 7.2 Sun Pharmaceutical
- 7.2.1 Sun Pharmaceutical Company Information
- 7.2.2 Sun Pharmaceutical Business Overview
- 7.2.3 Sun Pharmaceutical Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sun Pharmaceutical Eszopiclone Product Portfolio
- 7.2.5 Sun Pharmaceutical Recent Developments
- 7.3 Kanghong Pharmaceutical
- 7.3.1 Kanghong Pharmaceutical Company Information
- 7.3.2 Kanghong Pharmaceutical Business Overview
- 7.3.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 7.3.5 Kanghong Pharmaceutical Recent Developments
- 7.4 Wockhardt
- 7.4.1 Wockhardt Company Information
- 7.4.2 Wockhardt Business Overview
- 7.4.3 Wockhardt Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Wockhardt Eszopiclone Product Portfolio
- 7.4.5 Wockhardt Recent Developments
- 7.5 Tapi Teva
- 7.5.1 Tapi Teva Company Information
- 7.5.2 Tapi Teva Business Overview
- 7.5.3 Tapi Teva Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Tapi Teva Eszopiclone Product Portfolio
- 7.5.5 Tapi Teva Recent Developments
- 7.6 Shanghai Pharmaceuticals Holding
- 7.6.1 Shanghai Pharmaceuticals Holding Company Information
- 7.6.2 Shanghai Pharmaceuticals Holding Business Overview
- 7.6.3 Shanghai Pharmaceuticals Holding Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio
- 7.6.5 Shanghai Pharmaceuticals Holding Recent Developments
- 7.7 Kanghong Pharmaceutical
- 7.7.1 Kanghong Pharmaceutical Company Information
- 7.7.2 Kanghong Pharmaceutical Business Overview
- 7.7.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 7.7.5 Kanghong Pharmaceutical Recent Developments
- 7.8 Glenmark Life Sciences
- 7.8.1 Glenmark Life Sciences Company Information
- 7.8.2 Glenmark Life Sciences Business Overview
- 7.8.3 Glenmark Life Sciences Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Glenmark Life Sciences Eszopiclone Product Portfolio
- 7.8.5 Glenmark Life Sciences Recent Developments
- 7.9 Dr. Reddy’s Laboratories
- 7.9.1 Dr. Reddy’s Laboratories Company Information
- 7.9.2 Dr. Reddy’s Laboratories Business Overview
- 7.9.3 Dr. Reddy’s Laboratories Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Dr. Reddy’s Laboratories Eszopiclone Product Portfolio
- 7.9.5 Dr. Reddy’s Laboratories Recent Developments
- 7.10 Centaur Pharmaceuticals
- 7.10.1 Centaur Pharmaceuticals Company Information
- 7.10.2 Centaur Pharmaceuticals Business Overview
- 7.10.3 Centaur Pharmaceuticals Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Centaur Pharmaceuticals Eszopiclone Product Portfolio
- 7.10.5 Centaur Pharmaceuticals Recent Developments
- 7.11 Admiron Life
- 7.11.1 Admiron Life Company Information
- 7.11.2 Admiron Life Business Overview
- 7.11.3 Admiron Life Eszopiclone Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Admiron Life Eszopiclone Product Portfolio
- 7.11.5 Admiron Life Recent Developments
8 North America
- 8.1 North America Eszopiclone Market Size by Type
- 8.1.1 North America Eszopiclone Revenue by Type (2021-2032)
- 8.1.2 North America Eszopiclone Sales by Type (2021-2032)
- 8.1.3 North America Eszopiclone Price by Type (2021-2032)
- 8.2 North America Eszopiclone Market Size by Application
- 8.2.1 North America Eszopiclone Revenue by Application (2021-2032)
- 8.2.2 North America Eszopiclone Sales by Application (2021-2032)
- 8.2.3 North America Eszopiclone Price by Application (2021-2032)
- 8.3 North America Eszopiclone Market Size by Country
- 8.3.1 North America Eszopiclone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Eszopiclone Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Eszopiclone Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Eszopiclone Market Size by Type
- 9.1.1 Europe Eszopiclone Revenue by Type (2021-2032)
- 9.1.2 Europe Eszopiclone Sales by Type (2021-2032)
- 9.1.3 Europe Eszopiclone Price by Type (2021-2032)
- 9.2 Europe Eszopiclone Market Size by Application
- 9.2.1 Europe Eszopiclone Revenue by Application (2021-2032)
- 9.2.2 Europe Eszopiclone Sales by Application (2021-2032)
- 9.2.3 Europe Eszopiclone Price by Application (2021-2032)
- 9.3 Europe Eszopiclone Market Size by Country
- 9.3.1 Europe Eszopiclone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Eszopiclone Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Eszopiclone Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Eszopiclone Market Size by Type
- 10.1.1 China Eszopiclone Revenue by Type (2021-2032)
- 10.1.2 China Eszopiclone Sales by Type (2021-2032)
- 10.1.3 China Eszopiclone Price by Type (2021-2032)
- 10.2 China Eszopiclone Market Size by Application
- 10.2.1 China Eszopiclone Revenue by Application (2021-2032)
- 10.2.2 China Eszopiclone Sales by Application (2021-2032)
- 10.2.3 China Eszopiclone Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Eszopiclone Market Size by Type
- 11.1.1 Asia Eszopiclone Revenue by Type (2021-2032)
- 11.1.2 Asia Eszopiclone Sales by Type (2021-2032)
- 11.1.3 Asia Eszopiclone Price by Type (2021-2032)
- 11.2 Asia Eszopiclone Market Size by Application
- 11.2.1 Asia Eszopiclone Revenue by Application (2021-2032)
- 11.2.2 Asia Eszopiclone Sales by Application (2021-2032)
- 11.2.3 Asia Eszopiclone Price by Application (2021-2032)
- 11.3 Asia Eszopiclone Market Size by Country
- 11.3.1 Asia Eszopiclone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Eszopiclone Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Eszopiclone Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Eszopiclone Market Size by Type
- 12.1.1 SAMEA Eszopiclone Revenue by Type (2021-2032)
- 12.1.2 SAMEA Eszopiclone Sales by Type (2021-2032)
- 12.1.3 SAMEA Eszopiclone Price by Type (2021-2032)
- 12.2 SAMEA Eszopiclone Market Size by Application
- 12.2.1 SAMEA Eszopiclone Revenue by Application (2021-2032)
- 12.2.2 SAMEA Eszopiclone Sales by Application (2021-2032)
- 12.2.3 SAMEA Eszopiclone Price by Application (2021-2032)
- 12.3 SAMEA Eszopiclone Market Size by Country
- 12.3.1 SAMEA Eszopiclone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Eszopiclone Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Eszopiclone Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Eszopiclone Value Chain Analysis
- 13.1.1 Eszopiclone Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Eszopiclone Production Mode & Process
- 13.2 Eszopiclone Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Eszopiclone Distributors
- 13.2.3 Eszopiclone Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst